Fertility and Pregnancy Rapid Test Kits Market is projected to increase valuation of US$ 1.34 Bn in 2022 to US$ 1.88 Bn by 2030.

[183 Pages Report] Future Market Insights estimates that fertility and pregnancy rapid test kit market will experience a spike in sales in 2022, reaching US$ ~ 1.3 Bn by the year end. The recently released report by award winning research firm, examine the data pertaining to increased cases of gynecological disorders such as uterine polyps, fibroids, polycystic ovarian disease, and unexplained infertility worldwide over past decade.

A three layered data of rapid pregnancy fertility test kits penetration across different channel and average monthly sales has been collected and global market statistics has been calibrated.

Consumer spending on self-diagnosis has increase by two fold in last three year, which is subjected to high associated and recurring cost for opting services from professional pathology labs. Raid test kits is convenient and comes with low complexity which captivate potential customers.

The report provides detail on other associated factors that has propelled the demand for these kits. One of such factor include the widespread availability of fertility and pregnancy rapid test kits on online sales channel as well its categorization as OTC product.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-607

Dual Capability Tests To boost The Sales of Fertility And Pregnancy Rapid Test Kits

Manufacturers are providing pregnancy test kits with dual capability and are also offering combined packs of fertility and pregnancy rapid tests, which can be used to qualitatively detect the presence of HCG hormone in both – urine and serum/blood. Users are rapidly adopting these combo kits as this eliminates the necessity to buy separate kits for urine and blood/serum testing. For instance, various products such as QuickVue HCG Combo, Test & Confirm, ICON 25 HCG, and many others are available commercially; which prove to be cost-effective. Covid-19 is adding to the sales of home-made combo kits; as social distancing forbids them from visiting the labs for tests.

Key Takeaways of Fertility and Pregnancy Rapid Test Market Study        

• Among distribution channels segmentation, pharmacies and drug stores are expected to hold nearly 50% of the market share
• Rising age of first time pregnancy in North America is one of the major factors that drive its growth to the leading position in the market.

“Considering the rising adoption of fertility and pregnancy rapid testing kits, online sales platforms and OTC arms of the companies offer sizable opportunities for potential global market growth.” says the FMI analyst

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-607

Collaborations with e-Commerce Partners – A Key Strategy

The market for fertility and pregnancy test kits is rapidly growing and key players are looking for strategic options to expand globally. While most players have a fairly good distribution network locally as well as globally, the strong competition presses these players to look for options to reach out to more number of customers to sustain in the market.

Most companies focus on sales of fertility and pregnancy test kits through online sales channels. With products available online, buyers can choose from a wide variety of products to best suit their requirements. For instance many e-commerce portals such as Walmart, Amazon Inc., etc. offer variety of brands with discounted prices which attract the buyer.

Church & Dwight Co. Ltd., a major company in pregnancy and fertility test market generated 24% share of total revenue from sale of products through online distribution partner WalMart. PharmEasy is amongst the online pharmacy stores who delivers medicines to 98% PIN codes in India.

Want more insights?

Fertility and pregnancy rapid test market, a new study from Future Market Insights, opines on the fertility and pregnancy rapid test from 2012 – 2021 and presents demand projections from 2022 – 2030 on the basis of product (pregnancy rapid test (line-indicator devices (strips/dip sticks, mid-stream and cassettes) and digital devices and fertility rapid test (line-indicators and digital devices)), test type (LH urine, FSH urine, hCG blood, hCG urine), and distribution channel (pharmacies, drug stores, gynecology/fertility clinics, e-commerse and hypermarkets/supermarkets) across seven prominent regions.

Key Players :

• Alere Inc.
• Quidel Corporation
• Prestige Brands Holdings, Inc.
• Church & Dwight Co., Inc.
• bioMérieux SA
• Geratherm Medical AG
• Abbott Laboratories
• Procter & Gamble Co.
• DCC Plc.
• Swiss Precision Diagnostics GmbH

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-607

• Pregnancy Rapid Tests
  • Line-Indicator devices
    • Strips/Dip Sticks
    • Mid-Stream
    • Cassettes
  • Digital
• Fertility Rapid Tests
  • Line-Indicator
  • Digital

By Test Type :

• LH Urine
• FSH Urine
• hCG Blood
• hCG Urine

By Distribution channel :

• Pharmacy
• Drugstore
• Gynecology/Fertility Clinics
• e-commerce
• Hypermarkets & Supermarkets

By Region :

• North America
• Latin America
• Western Europe
• Eastern Europe
• APEJ
• MEA
• Japan

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs